Is there a link between inflammation and abnormal lipoprotein profile in Sjögren's syndrome?

Joint Bone Spine

Volumn 77, Issue 3, 2010, Pages 229-231

  Cruz, Willian ^a   Fialho, Sonia ^a   Morato, Edelton ^a   Castro, Gláucio ^a   Zimmermann, Adriana ^a   Ribeiro, Giovana ^a   Neves, Fabrício ^a   Pereira, Ivânio ^a  

^a FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

Author keywords

Inflammation; Lipoprotein profile; Sj gren's syndrome

Indexed keywords

ANTINUCLEAR ANTIBODY; C REACTIVE PROTEIN; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; LA ANTIBODY; LOW DENSITY LIPOPROTEIN; RHEUMATOID FACTOR; RO ANTIBODY; TRIACYLGLYCEROL;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DYSLIPIDEMIA; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; HYPERGAMMAGLOBULINEMIA; INFLAMMATION; LABORATORY TEST; LIPID ANALYSIS; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PATIENT ASSESSMENT; RHEUMATOID ARTHRITIS; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; AGED; ANTIBODIES, ANTINUCLEAR; BIOLOGICAL MARKERS; BLOOD SEDIMENTATION; C-REACTIVE PROTEIN; CROSS-SECTIONAL STUDIES; DYSLIPIDEMIAS; FEMALE; HUMANS; HYPERGAMMAGLOBULINEMIA; INFLAMMATION; LIPOPROTEINS; MALE; MIDDLE AGED; RHEUMATOID FACTOR; SJOGREN'S SYNDROME;

EID: 77952552225     PISSN: 1297319X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jbspin.2010.02.011     Document Type: Article

References (17)

1. Mallika V., Goswani B., and Rajappa M. Atherosclerosis pathophysiology and the role of novel risk factors: a clinicobiochemical perspective. Angiology 58 5 (2007) 513-522
2. Sherer Y., and Shoenfeld Y. Mechanisms of disease: atherosclerosis in autoimmune diseases. Nat Clin Pract Rheumatol 2 2 (2006) 99-106
3. Murphy S.A., Cannon C.P., Wiviott S.D., et al. Effect of intensive lipid-lowering therapy on mortality after acute coronary syndrome (a patient-level analysis of the Aggrastat to Zocor and Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 trials). Am J Cardiol 100 7 (2007) 1047-1051
4. Fuentes B., Martínez-Sánchez P., and Díez-Tejedor E. Lipid-lowering drugs in ischemic stroke prevention and their influence on acute stroke outcome. Cerebrovasc Dis 27 Suppl. 1 (2009) 126-133
5. Lodde B.M., Sankar V., Kok M.R., et al. Serum Lipid Levels in Sjogren's Syndrome. Rheumatology 45 (2006) 481-484
6. Vitali C., Bombardieri S., Jonsson R., et al. Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 61 6 (2002) 554-558
7. Grundy S., Cleeman J., Merz C., et al. Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines. Circulation 110 (2004) 227-239
8. Shoenfeld Y., Gerli R., Doria A., et al. Accelerated atherosclerosis in autoimmune rheumatic diseases. Circulation 112 (2005) 3337-3347
9. Theander E., Manthorpe R., and Jacobsson L. Mortality and causes of death in primary Sjogren's syndrome. A prospective cohort study. Arthritis Rheum 50 (2004) 1262-1269
10. Vaudo G., Bartoloni E., Shoenfeld Y., et al. Precocious intima-media thickening in patients with primary Sjogren's syndrome. Arthritis Rheum 52 (2005) 3890-3897
11. Danesh J., Collins R., and Peto R. Chronic infections and coronary heart disease: is there a link?. Lancet 350 (1997) 430-436
12. Ridker P.M., Cushman M., Stampfer M.J., et al. Inflammation, aspirin, and risk of cardiovascular disease in apparently healthy men. N Engl J Med 336 (1997) 973-979
13. Hatanaka K., Li X.A., Masuda K., et al. Immunohistochemical localization of C-reactive protein-binding sites in human atherosclerotic aortic lesions by a modified streptavidin-biotin-staining method. Pathol Int 45 (1995) 635-641
14. Lagrand W.K., Niessen J.W.M., Wolbink G.J., et al. C-reactive protein colocalizes with complement in human hearts during acute myocardial infarction. Circulation 95 (1997) 97-103
15. Shoenfeld Y., Gerli R., Doria A., et al. Accelerated atherosclerosis in autoimmune rheumatic diseases. Circulation 112 21 (2005) 3337-3347
16. Steiner G., and Urowitz M.B. Lipid profiles in patients with rheumatoid arthritis: mechanisms and the impact of treatment. Semin Arthritis Rheum 38 5 (2009) 372-381
17. Rosolova H., Petrlova B., Simon J., et al. High-sensitivity C-reactive protein and the hypertriglyceridemic waist in patients with type 2 diabetes and metabolic syndrome. Med Sci Monit 14 8 (2008) CR411-CR415